PRASUGREL

PRASUGREL was reported 10151 times

PRASUGREL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BASILAR ARTERY PERFORATION 1 0.5000
1 ISCHAEMIC MITRAL REGURGITATION 2 0.2500
2 OPHTHALMIC ARTERY OCCLUSION 9 0.1552
3 VIRAL TONSILLITIS 7 0.1250
4 CEREBROVASCULAR ARTERIOVENOUS MALFORMATION 9 0.1034
5 ANEURYSM THROMBOSIS 1 0.0769
6 CARDIAC VENTRICULAR SCARRING 1 0.0667
7 FACTOR V INHIBITION 10 0.0515
8 ANGINAL EQUIVALENT 1 0.0500
9 CRUSH SYNDROME 7 0.0496
10 OBSTRUCTIVE SHOCK 5 0.0459
11 ALBINISM 1 0.0435
12 PHAEOCHROMOCYTOMA CRISIS 8 0.0377
13 VASCULAR STENT THROMBOSIS 75 0.0368
14 SCROTAL HAEMATOMA 3 0.0316
15 COAGULATION FACTOR V LEVEL DECREASED 10 0.0307
16 MYOCARDIAL HAEMORRHAGE 3 0.0273
17 VASCULAR STENT STENOSIS 11 0.0261
18 REOCCLUSION 2 0.0256
19 MYOCARDIAL CALCIFICATION 3 0.0256
20 ARTERIAL INTRAMURAL HAEMATOMA 2 0.0250
21 HEPARIN RESISTANCE 3 0.0246
22 VASCULAR STENT OCCLUSION 9 0.0223
23 OESOPHAGEAL INTRAMURAL HAEMATOMA 2 0.0190
24 LIPID METABOLISM DISORDER 7 0.0182
25 MEDIASTINAL HAEMATOMA 3 0.0181
26 PLATELET FUNCTION TEST ABNORMAL 4 0.0179
27 APNOEIC ATTACK 10 0.0177
28 ACUTE RIGHT VENTRICULAR FAILURE 3 0.0176
29 VASCULAR PSEUDOANEURYSM 29 0.0166
30 CAROTID ARTERIOSCLEROSIS 17 0.0165
31 VESSEL PERFORATION 2 0.0152
32 CERVICOGENIC HEADACHE 2 0.0147
33 PROSTATIC ABSCESS 4 0.0145
34 CARDIAC PSEUDOANEURYSM 1 0.0145
35 OCULAR RETROBULBAR HAEMORRHAGE 2 0.0144
36 MYOCARDIAL STRAIN 2 0.0144
37 DUODENITIS HAEMORRHAGIC 2 0.0144
38 ATHEROSCLEROTIC PLAQUE RUPTURE 1 0.0137
39 HYPERLIPASAEMIA 7 0.0134
40 PHARYNGEAL NEOPLASM 2 0.0129
41 ABDOMINAL SYMPTOM 10 0.0124
42 BASILAR ARTERY THROMBOSIS 2 0.0111
43 BRAIN STEM ISCHAEMIA 2 0.0111
44 BRCA2 GENE MUTATION 1 0.0105
45 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 4 0.0104
46 SPINAL EPIDURAL HAEMATOMA 6 0.0102
47 CORONARY ARTERY RESTENOSIS 6 0.0100
48 BLADDER TAMPONADE 3 0.0099
49 HAEMOBILIA 4 0.0096
50 ADMINISTRATION SITE HAEMORRHAGE 1 0.0096
51 LIPOPROTEIN (A) INCREASED 3 0.0092
52 THROMBOLYSIS 2 0.0090
53 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 4 0.0089
54 ARTERIAL RESTENOSIS 1 0.0085
55 AUTOIMMUNE HYPOTHYROIDISM 2 0.0084
56 ARTERIOVENOUS FISTULA 4 0.0081
57 ACETONAEMIA 2 0.0079
58 AORTIC INTRAMURAL HAEMATOMA 1 0.0077
59 DIABETIC METABOLIC DECOMPENSATION 10 0.0072
60 HAEMORRHAGIC ASCITES 2 0.0070
61 ANASTOMOTIC ULCER HAEMORRHAGE 1 0.0070
62 HYPOURICAEMIA 2 0.0069
63 ACCELERATED IDIOVENTRICULAR RHYTHM 1 0.0068
64 INTRAVENTRICULAR HAEMORRHAGE 16 0.0064
65 PROTHROMBIN TIME SHORTENED 9 0.0064
66 OESOPHAGEAL CANCER METASTATIC 2 0.0063
67 BONE FISTULA 1 0.0063
68 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 54 0.0061
69 IMMUNE-MEDIATED THYROIDITIS 3 0.0061
70 CAROTID ARTERY ANEURYSM 2 0.0058
71 THROMBOSIS IN DEVICE 19 0.0058
72 CEREBELLAR HAEMORRHAGE 8 0.0056
73 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 2 0.0056
74 CHRONIC LEFT VENTRICULAR FAILURE 2 0.0056
75 TONIC CLONIC MOVEMENTS 7 0.0054
76 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 5 0.0053
77 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 1 0.0053
78 INTRACRANIAL HAEMATOMA 3 0.0053
79 GALLBLADDER PERFORATION 2 0.0052
80 ATONIC URINARY BLADDER 1 0.0052
81 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 21 0.0051
82 ACQUIRED HAEMOPHILIA 5 0.0050
83 VASCULAR OPERATION 2 0.0050
84 CORONARY ARTERY THROMBOSIS 10 0.0050
85 LICHENIFICATION 2 0.0049
86 ARTERY DISSECTION 2 0.0048
87 URINARY BLADDER HAEMORRHAGE 10 0.0047
88 AUTOINFLAMMATORY DISEASE 1 0.0047
89 OESOPHAGEAL DILATATION 2 0.0045
90 CORONARY ARTERY STENOSIS 22 0.0044
91 CARDIAC PERFORATION 1 0.0043
92 METASTASES TO ADRENALS 4 0.0043
93 URINARY TRACT INFECTION ENTEROCOCCAL 4 0.0043
94 PUNCTURE SITE HAEMORRHAGE 3 0.0042
95 CRANIAL NERVE PARALYSIS 2 0.0042
96 ARRESTED LABOUR 1 0.0042
97 BLOOD IMMUNOGLOBULIN E INCREASED 10 0.0041
98 PERICARDIAL HAEMORRHAGE 9 0.0041
99 CEREBRAL VASOCONSTRICTION 3 0.0041
100 DERMATOMYOSITIS 10 0.0039
101 ADAMTS13 ACTIVITY DECREASED 1 0.0039
102 BRONCHIAL CARCINOMA 3 0.0038
103 BRAIN MIDLINE SHIFT 2 0.0038
104 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
105 ARTERIAL STENT INSERTION 1 0.0037
106 ACUTE MYOCARDIAL INFARCTION 108 0.0037
107 IMMUNE-MEDIATED MYOSITIS 10 0.0036
108 POTENTIATING DRUG INTERACTION 12 0.0036
109 ARTERIAL HAEMORRHAGE 4 0.0035
110 THERAPEUTIC PRODUCT CROSS-REACTIVITY 3 0.0034
111 CREPITATIONS 10 0.0034
112 HAEMATOMA MUSCLE 4 0.0033
113 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 11 0.0033
114 CARDIAC DEATH 4 0.0033
115 GASTROINTESTINAL POLYP HAEMORRHAGE 2 0.0033
116 ANEURYSM 16 0.0032
117 BRONCHIAL HAEMORRHAGE 1 0.0032
118 BED REST 1 0.0032
119 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 12 0.0031
120 DIVERTICULUM INTESTINAL HAEMORRHAGIC 7 0.0031
121 HYPOCOAGULABLE STATE 3 0.0031
122 LISTLESS 10 0.0030
123 PHAEOCHROMOCYTOMA 2 0.0030
124 POST PROCEDURAL SEPSIS 2 0.0030
125 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
126 DIABETIC RETINOPATHY 10 0.0029
127 ASTHMA EXERCISE INDUCED 1 0.0029
128 PEPTIC ULCER HAEMORRHAGE 2 0.0029
129 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0028
130 FALSE NEGATIVE INVESTIGATION RESULT 2 0.0028
131 RETROPERITONEAL HAEMORRHAGE 7 0.0028
132 HYPERTENSIVE NEPHROPATHY 3 0.0028
133 TACHYARRHYTHMIA 7 0.0028
134 HAEMORRHAGIC DISORDER 3 0.0028
135 HAEMOTHORAX 8 0.0028
136 MYOPATHY 23 0.0027
137 MIXED LIVER INJURY 8 0.0027
138 KOUNIS SYNDROME 6 0.0026
139 ATRIOVENTRICULAR BLOCK SECOND DEGREE 8 0.0026
140 CORONARY ARTERY OCCLUSION 36 0.0026
141 COAGULATION TEST ABNORMAL 2 0.0026
142 MUSCLE RUPTURE 10 0.0026
143 HYPOVOLAEMIC SHOCK 12 0.0025
144 HAEMOPERITONEUM 2 0.0025
145 TUMOUR EXCISION 2 0.0025
146 IRON DEFICIENCY 11 0.0024
147 POLYCYTHAEMIA VERA 2 0.0024
148 PHARYNGEAL HAEMORRHAGE 3 0.0024
149 AORTIC OCCLUSION 1 0.0024
150 CARDIAC VENTRICULAR DISORDER 1 0.0024
151 INTRA-ABDOMINAL HAEMATOMA 3 0.0024
152 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 12 0.0024
153 GASTRIC ULCER PERFORATION 3 0.0024
154 PYLORIC STENOSIS 2 0.0024
155 CAROTID ARTERY THROMBOSIS 2 0.0024
156 ANAL SPHINCTER ATONY 1 0.0023
157 CARDIAC VENTRICULAR THROMBOSIS 3 0.0023
158 ARTERIAL STENOSIS 2 0.0023
159 SHOCK HAEMORRHAGIC 18 0.0022
160 PERIPHERAL ISCHAEMIA 9 0.0022
161 ATYPICAL MYCOBACTERIAL INFECTION 3 0.0021
162 LOW DENSITY LIPOPROTEIN DECREASED 3 0.0021
163 INTRA-ABDOMINAL HAEMORRHAGE 5 0.0021
164 DUODENAL ULCER HAEMORRHAGE 6 0.0021
165 LABELLED DRUG-DRUG INTERACTION ISSUE 3 0.0021
166 PHOTOPSIA 13 0.0021
167 BREATH SOUNDS ABNORMAL 10 0.0020
168 HIGH DENSITY LIPOPROTEIN INCREASED 2 0.0020
169 PRINZMETAL ANGINA 2 0.0020
170 HAEMORRHAGIC TRANSFORMATION STROKE 3 0.0020
171 STENT PLACEMENT 16 0.0020
172 ILEAL ULCER 2 0.0020
173 BRAIN STEM INFARCTION 2 0.0020
174 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 3 0.0020
175 COAGULATION TIME PROLONGED 3 0.0019
176 URETEROLITHIASIS 2 0.0019
177 INFARCTION 13 0.0019
178 SYSTOLIC DYSFUNCTION 2 0.0019
179 INTERMITTENT CLAUDICATION 3 0.0019
180 CARDIOGENIC SHOCK 27 0.0019
181 CEREBRAL ARTERY OCCLUSION 2 0.0019
182 CLAUSTROPHOBIA 2 0.0018
183 RETROPERITONEAL HAEMATOMA 4 0.0018
184 GASTRIC ULCER HAEMORRHAGE 10 0.0018
185 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
186 PUPIL FIXED 3 0.0017
187 SPINAL CORD INJURY 3 0.0017
188 THROMBOTIC THROMBOCYTOPENIC PURPURA 6 0.0017
189 HAEMATOMA 44 0.0017
190 ANGINA UNSTABLE 11 0.0017
191 CORONARY ARTERY DISEASE 51 0.0017
192 CARDIAC TAMPONADE 8 0.0017
193 PROTHROMBIN TIME PROLONGED 10 0.0017
194 CARDIAC PROCEDURE COMPLICATION 1 0.0016
195 ATRIAL FLUTTER 13 0.0016
196 HAEMORRHAGIC ANAEMIA 7 0.0016
197 HYPOMAGNESAEMIA 22 0.0016
198 CORONARY ARTERIAL STENT INSERTION 8 0.0016
199 SUBARACHNOID HAEMORRHAGE 16 0.0016
200 ARTERIAL DISORDER 3 0.0016
201 ACUTE CORONARY SYNDROME 13 0.0016
202 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2 0.0016
203 NOCARDIOSIS 4 0.0016
204 DRUG RESISTANCE 40 0.0016
205 LIBIDO DISORDER 2 0.0015
206 PROCEDURAL HAEMORRHAGE 6 0.0015
207 ARTERIOSPASM CORONARY 6 0.0015
208 RENAL HAEMORRHAGE 3 0.0015
209 ISCHAEMIC HEPATITIS 2 0.0015
210 AKINESIA 3 0.0014
211 ANAL HAEMORRHAGE 4 0.0014
212 PERIPHERAL ARTERY OCCLUSION 2 0.0014
213 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
214 CAROTID ARTERY OCCLUSION 5 0.0014
215 UPPER GASTROINTESTINAL HAEMORRHAGE 23 0.0014
216 AORTIC VALVE SCLEROSIS 1 0.0014
217 ACUTE ABDOMEN 2 0.0014
218 MELAENA 30 0.0014
219 VENTRICULAR EXTRASYSTOLES 14 0.0013
220 GASTRITIS HAEMORRHAGIC 2 0.0013
221 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
222 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
223 BLOOD LOSS ANAEMIA 3 0.0013
224 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
225 CONTRAST MEDIA REACTION 3 0.0013
226 POLYMYALGIA RHEUMATICA 4 0.0013
227 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
228 AORTIC VALVE DISEASE 2 0.0012
229 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
230 RESUSCITATION 2 0.0012
231 CARDIAC STRESS TEST ABNORMAL 1 0.0012
232 TROPONIN I INCREASED 2 0.0012
233 HYPERPARATHYROIDISM SECONDARY 3 0.0012
234 CEREBRAL HAEMATOMA 4 0.0012
235 RHABDOMYOLYSIS 49 0.0012
236 HYPOCALCAEMIA 22 0.0012
237 TYPE 1 DIABETES MELLITUS 7 0.0012
238 MYCOBACTERIAL INFECTION 2 0.0012
239 HAEMORRHAGE INTRACRANIAL 17 0.0011
240 CATHETERISATION CARDIAC 5 0.0011
241 ESSENTIAL HYPERTENSION 2 0.0011
242 ANEURYSM RUPTURED 1 0.0011
243 PARADOXICAL DRUG REACTION 4 0.0011
244 OPPORTUNISTIC INFECTION 2 0.0011
245 NEPHROGENIC ANAEMIA 5 0.0011
246 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
247 GASTRITIS EROSIVE 5 0.0011
248 BLOOD IRON INCREASED 2 0.0011
249 EYE HAEMORRHAGE 14 0.0010
250 COMA SCALE ABNORMAL 3 0.0010
251 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
252 ABDOMINAL WALL HAEMATOMA 2 0.0010
253 HYPOGEUSIA 2 0.0010
254 MYOCARDIAL INFARCTION 177 0.0010
255 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 26 0.0010
256 CARDIAC ANEURYSM 1 0.0010
257 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 5 0.0010
258 SMALL INTESTINAL HAEMORRHAGE 2 0.0010
259 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
260 POLYURIA 8 0.0010
261 ATRIAL THROMBOSIS 2 0.0010
262 CHEST INJURY 2 0.0010
263 ARTERIOSCLEROSIS 9 0.0010
264 GINGIVAL BLEEDING 13 0.0010
265 CEREBRAL HAEMORRHAGE 34 0.0009
266 SLEEP APNOEA SYNDROME 18 0.0009
267 CARDIAC FAILURE CHRONIC 4 0.0009
268 VENTRICULAR HYPOKINESIA 3 0.0009
269 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
270 DIABETIC KETOACIDOSIS 22 0.0009
271 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
272 SUBDURAL HAEMATOMA 13 0.0009
273 COLONOSCOPY 2 0.0009
274 ANGINA PECTORIS 26 0.0009
275 EJECTION FRACTION DECREASED 14 0.0009
276 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
277 SUDDEN CARDIAC DEATH 3 0.0009
278 MYOCARDIAL ISCHAEMIA 10 0.0009
279 ADMINISTRATION SITE PAIN 1 0.0009
280 AORTIC THROMBOSIS 1 0.0009
281 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
282 CAROTID ARTERY STENOSIS 3 0.0009
283 DIPLOPIA 22 0.0008
284 BLEEDING TIME PROLONGED 1 0.0008
285 PRODUCT PACKAGING CONFUSION 2 0.0008
286 THROMBOCYTOSIS 3 0.0008
287 DRUG ADMINISTRATION ERROR 25 0.0008
288 WOUND HAEMORRHAGE 3 0.0008
289 CARTILAGE INJURY 2 0.0008
290 HYPERCALCAEMIA 10 0.0008
291 FEELING DRUNK 6 0.0008
292 HEPATIC STEATOSIS 15 0.0008
293 RETINOPATHY 3 0.0008
294 EPISTAXIS 60 0.0008
295 PLATELET DISORDER 2 0.0008
296 INTERNAL HAEMORRHAGE 9 0.0008
297 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
298 GASTRIC HAEMORRHAGE 9 0.0008
299 OESOPHAGEAL DISORDER 3 0.0008
300 GASTROINTESTINAL HAEMORRHAGE 65 0.0008
301 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
302 HEPATITIS ACUTE 5 0.0008
303 RENAL CYST 6 0.0008
304 ANION GAP INCREASED 1 0.0007
305 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
306 ORGAN FAILURE 3 0.0007
307 SHOULDER ARTHROPLASTY 2 0.0007
308 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
309 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
310 HYPERCHOLESTEROLAEMIA 7 0.0007
311 VITREOUS HAEMORRHAGE 2 0.0007
312 BLOOD TEST ABNORMAL 10 0.0007
313 AORTIC VALVE INCOMPETENCE 3 0.0007
314 INTERVERTEBRAL DISC DISORDER 3 0.0007
315 DRUG-INDUCED LIVER INJURY 22 0.0007
316 TUMOUR HAEMORRHAGE 2 0.0007
317 DRUG INTERACTION 111 0.0007
318 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
319 PARAPLEGIA 2 0.0007
320 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
321 MONOPLEGIA 3 0.0007
322 DYSPNOEA AT REST 2 0.0007
323 LIVER FUNCTION TEST ABNORMAL 20 0.0007
324 BILIARY COLIC 2 0.0007
325 GASTROINTESTINAL NECROSIS 2 0.0007
326 PULMONARY PAIN 2 0.0007
327 HYPERCHLORHYDRIA 4 0.0007
328 HAEMATURIA 23 0.0007
329 ANGIOPLASTY 1 0.0007
330 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
331 REBOUND ACID HYPERSECRETION 2 0.0007
332 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
333 IMMUNE THROMBOCYTOPENIA 3 0.0007
334 DUODENITIS 2 0.0007
335 INTRACARDIAC THROMBUS 2 0.0007
336 DIASTOLIC DYSFUNCTION 2 0.0006
337 MULTIPLE-DRUG RESISTANCE 2 0.0006
338 HAEMORRHAGIC STROKE 5 0.0006
339 SUSPECTED SUICIDE 3 0.0006
340 NON-CARDIAC CHEST PAIN 2 0.0006
341 VENTRICULAR FIBRILLATION 7 0.0006
342 TRICUSPID VALVE INCOMPETENCE 5 0.0006
343 LACTIC ACIDOSIS 20 0.0006
344 VITAMIN D DEFICIENCY 6 0.0006
345 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
346 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
347 BRADYARRHYTHMIA 1 0.0006
348 DIABETIC NEUROPATHY 3 0.0006
349 CYTOLYTIC HEPATITIS 2 0.0006
350 LYME DISEASE 2 0.0006
351 PNEUMONITIS 16 0.0006
352 IMPAIRED GASTRIC EMPTYING 8 0.0006
353 ECCHYMOSIS 4 0.0006
354 PETECHIAE 6 0.0006
355 AORTIC STENOSIS 2 0.0006
356 PARTIAL SEIZURES 3 0.0006
357 OBESITY 9 0.0006
358 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
359 HAEMORRHAGE 58 0.0006
360 OROPHARYNGEAL DISCOMFORT 5 0.0006
361 BLOOD PRESSURE ABNORMAL 11 0.0006
362 HAEMATEMESIS 14 0.0006
363 HEPATIC CYTOLYSIS 7 0.0005
364 HYPERKERATOSIS 3 0.0005
365 INCREASED TENDENCY TO BRUISE 5 0.0005
366 HAEMOPTYSIS 15 0.0005
367 CARDIAC DYSFUNCTION 2 0.0005
368 BLOOD CHOLESTEROL DECREASED 1 0.0005
369 RECTAL HAEMORRHAGE 23 0.0005
370 ACUTE PULMONARY OEDEMA 3 0.0005
371 MITRAL VALVE INCOMPETENCE 6 0.0005
372 BLOOD BICARBONATE DECREASED 1 0.0005
373 BILE DUCT OBSTRUCTION 1 0.0005
374 TROPONIN INCREASED 4 0.0005
375 HAEMODYNAMIC INSTABILITY 4 0.0005
376 GASTRIC INFECTION 2 0.0005
377 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
378 DRUG PRESCRIBING ERROR 10 0.0005
379 CHEST PAIN 96 0.0005
380 ARTERIAL THROMBOSIS 1 0.0005
381 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
382 SINUS BRADYCARDIA 5 0.0005
383 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
384 POST PROCEDURAL HAEMORRHAGE 6 0.0005
385 PRODUCT LABEL CONFUSION 3 0.0005
386 ALCOHOL INTERACTION 1 0.0005
387 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
388 ORAL INFECTION 2 0.0005
389 OESOPHAGEAL PAIN 2 0.0005
390 ACCIDENT 6 0.0005
391 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
392 SKIN PAPILLOMA 2 0.0005
393 MUSCLE HAEMORRHAGE 2 0.0005
394 DEVICE OCCLUSION 7 0.0005
395 TOXIC SKIN ERUPTION 5 0.0005
396 HYPOGLYCAEMIA 24 0.0005
397 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
398 VITAMIN B12 DEFICIENCY 2 0.0005
399 VENTRICULAR TACHYCARDIA 8 0.0005
400 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
401 COAGULOPATHY 8 0.0005
402 MUSCLE FATIGUE 2 0.0005
403 BUNDLE BRANCH BLOCK LEFT 2 0.0005
404 ACUTE RESPIRATORY FAILURE 9 0.0005
405 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
406 THROMBOSIS 37 0.0005
407 POLYP 3 0.0005
408 URINE OUTPUT DECREASED 4 0.0005
409 DIVERTICULUM INTESTINAL 2 0.0005
410 PHARYNGEAL OEDEMA 7 0.0005
411 CARDIAC FAILURE ACUTE 3 0.0004
412 RHINITIS ALLERGIC 2 0.0004
413 MYOSITIS 4 0.0004
414 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
415 ULCER HAEMORRHAGE 3 0.0004
416 END STAGE RENAL DISEASE 8 0.0004
417 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
418 ISCHAEMIA 2 0.0004
419 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
420 HYPERKALAEMIA 15 0.0004
421 DRUG LEVEL INCREASED 7 0.0004
422 MEDICATION RESIDUE PRESENT 2 0.0004
423 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
424 PRESYNCOPE 10 0.0004
425 LABORATORY TEST ABNORMAL 12 0.0004
426 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
427 INJECTION SITE INFLAMMATION 2 0.0004
428 HYPERNATRAEMIA 2 0.0004
429 BRADYCARDIA 21 0.0004
430 BRAIN OEDEMA 5 0.0004
431 AMMONIA INCREASED 2 0.0004
432 INCORRECT ROUTE OF DRUG ADMINISTRATION 14 0.0004
433 ATRIOVENTRICULAR BLOCK 3 0.0004
434 TYPE 2 DIABETES MELLITUS 13 0.0004
435 ACTINIC KERATOSIS 1 0.0004
436 PULMONARY HAEMORRHAGE 3 0.0004
437 MALABSORPTION 2 0.0004
438 GASTROINTESTINAL INFLAMMATION 3 0.0004
439 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
440 TRANSFUSION 4 0.0004
441 MYALGIA 64 0.0004
442 ANIMAL BITE 1 0.0004
443 AREFLEXIA 1 0.0004
444 OVERWEIGHT 2 0.0004
445 OEDEMA 20 0.0004
446 BLOOD URINE PRESENT 7 0.0004
447 ABDOMINAL RIGIDITY 1 0.0004
448 HYDROCEPHALUS 2 0.0004
449 CHOLESTASIS 7 0.0004
450 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
451 HEMIPARESIS 6 0.0004
452 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
453 ACUTE KIDNEY INJURY 54 0.0004
454 HEPATOCELLULAR INJURY 5 0.0004
455 DISTURBANCE IN ATTENTION 19 0.0004
456 IMPAIRED DRIVING ABILITY 4 0.0004
457 VITAMIN D DECREASED 3 0.0004
458 CARDIAC VALVE DISEASE 2 0.0003
459 CARDIAC OPERATION 3 0.0003
460 CORONARY ARTERY BYPASS 2 0.0003
461 IMPAIRED QUALITY OF LIFE 5 0.0003
462 SEPTIC SHOCK 15 0.0003
463 HYPOKINESIA 5 0.0003
464 HAEMATOCHEZIA 19 0.0003
465 STRESS CARDIOMYOPATHY 2 0.0003
466 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
467 PRODUCT COMMUNICATION ISSUE 3 0.0003
468 CARDIOMYOPATHY 5 0.0003
469 ISCHAEMIC STROKE 6 0.0003
470 PULMONARY OEDEMA 15 0.0003
471 BRAIN HERNIATION 1 0.0003
472 HYPERLIPIDAEMIA 4 0.0003
473 JAUNDICE 9 0.0003
474 ANAL INCONTINENCE 3 0.0003
475 BONE MARROW DISORDER 1 0.0003
476 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
477 PANIC ATTACK 12 0.0003
478 FIBROMYALGIA 8 0.0003
479 TREATMENT NONCOMPLIANCE 18 0.0003
480 INGUINAL HERNIA 2 0.0003
481 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
482 UROSEPSIS 3 0.0003
483 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
484 BRAIN DEATH 1 0.0003
485 HEPATIC ENCEPHALOPATHY 3 0.0003
486 AGEUSIA 8 0.0003
487 SWELLING OF EYELID 2 0.0003
488 DERMATITIS ALLERGIC 4 0.0003
489 CARDIAC ARREST 26 0.0003
490 BILE DUCT STONE 1 0.0003
491 HEPATOTOXICITY 7 0.0003
492 VERTIGO 19 0.0003
493 HAEMOGLOBIN ABNORMAL 2 0.0003
494 HYPERHIDROSIS 40 0.0003
495 UNRESPONSIVE TO STIMULI 8 0.0003
496 COELIAC DISEASE 3 0.0003
497 SOMNAMBULISM 2 0.0003
498 CHRONIC KIDNEY DISEASE 23 0.0003
499 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
500 CARDIAC FAILURE 24 0.0003
501 PRODUCT ADMINISTRATION ERROR 6 0.0003
502 BLOOD BILIRUBIN INCREASED 8 0.0003
503 PRODUCT LABEL ISSUE 2 0.0003
504 HEPATIC FUNCTION ABNORMAL 11 0.0003
505 PRODUCT PRESCRIBING ERROR 7 0.0003
506 ANGIOEDEMA 13 0.0003
507 CIRCULATORY COLLAPSE 5 0.0003
508 CHEST DISCOMFORT 30 0.0003
509 CONTUSION 28 0.0003
510 HYPERBILIRUBINAEMIA 3 0.0003
511 BLOOD CREATININE ABNORMAL 1 0.0003
512 LARGE INTESTINE POLYP 2 0.0003
513 MENTAL STATUS CHANGES 8 0.0003
514 COMPLETED SUICIDE 24 0.0003
515 HYPERTENSION 61 0.0003
516 TENDERNESS 3 0.0003
517 FORMICATION 2 0.0003
518 EOSINOPHILIA 5 0.0003
519 DIVERTICULUM 2 0.0003
520 METABOLIC ACIDOSIS 9 0.0003
521 SEPSIS 31 0.0003
522 ATRIAL FIBRILLATION 27 0.0003
523 FAECES DISCOLOURED 6 0.0003
524 PRODUCT DISPENSING ERROR 6 0.0003
525 OESOPHAGITIS 3 0.0003
526 CHOLELITHIASIS 9 0.0003
527 RESPIRATORY FAILURE 20 0.0003
528 MIGRAINE 26 0.0003
529 ALCOHOL USE 1 0.0003
530 TRANSAMINASES INCREASED 6 0.0003
531 HEPATIC FAILURE 8 0.0003
532 GASTRIC ULCER 5 0.0003
533 DEVICE FAILURE 4 0.0003
534 DIABETES MELLITUS 20 0.0003
535 ACIDOSIS 2 0.0003
536 PROCEDURAL COMPLICATION 2 0.0003
537 HYPOKALAEMIA 12 0.0003
538 METASTASES TO LUNG 3 0.0003
539 APNOEA 2 0.0003
540 PELVIC FRACTURE 2 0.0003
541 SWELLING 24 0.0003
542 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
543 ULCER 4 0.0003
544 PRESCRIBED UNDERDOSE 5 0.0003
545 CARDIAC FAILURE CONGESTIVE 20 0.0002
546 NIGHT SWEATS 8 0.0002
547 PRODUCT PHYSICAL ISSUE 5 0.0002
548 CHILLS 29 0.0002
549 PSORIATIC ARTHROPATHY 10 0.0002
550 POST PROCEDURAL INFECTION 2 0.0002
551 CYST 3 0.0002
552 AORTIC DISSECTION 1 0.0002
553 HEMIPLEGIA 2 0.0002
554 SYNCOPE 24 0.0002
555 URINARY RETENTION 8 0.0002
556 FACIAL PARALYSIS 2 0.0002
557 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
558 GASTRITIS 6 0.0002
559 GROIN PAIN 2 0.0002
560 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
561 PURPURA 2 0.0002
562 LIVER DISORDER 10 0.0002
563 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
564 CARDIAC DISORDER 21 0.0002
565 FACIAL PAIN 2 0.0002
566 PRODUCT TASTE ABNORMAL 3 0.0002
567 CHROMATURIA 5 0.0002
568 BLINDNESS 9 0.0002
569 PALLOR 6 0.0002
570 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
571 HEPATIC ENZYME INCREASED 15 0.0002
572 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
573 PERIPHERAL COLDNESS 3 0.0002
574 RENAL FAILURE 29 0.0002
575 BRAIN NEOPLASM 2 0.0002
576 ANAPHYLACTIC REACTION 12 0.0002
577 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
578 ORAL DISCOMFORT 3 0.0002
579 ANAEMIA 41 0.0002
580 ERYTHEMA MULTIFORME 2 0.0002
581 HAEMOGLOBIN DECREASED 22 0.0002
582 MIDDLE INSOMNIA 4 0.0002
583 APPENDICITIS 2 0.0002
584 FLANK PAIN 2 0.0002
585 PHOTOPHOBIA 4 0.0002
586 DYSARTHRIA 8 0.0002
587 DYSPNOEA EXERTIONAL 8 0.0002
588 RENAL FAILURE ACUTE 9 0.0002
589 SEASONAL ALLERGY 3 0.0002
590 BRONCHOSPASM 3 0.0002
591 RED BLOOD CELL COUNT DECREASED 6 0.0002
592 RECALLED PRODUCT ADMINISTERED 2 0.0002
593 HYPOTENSION 42 0.0002
594 GAIT DISTURBANCE 40 0.0002
595 LETHARGY 12 0.0002
596 DYSPNOEA 118 0.0002
597 POST PROCEDURAL COMPLICATION 4 0.0002
598 DIZZINESS POSTURAL 2 0.0002
599 INFLAMMATORY BOWEL DISEASE 2 0.0002
600 PHARYNGEAL SWELLING 2 0.0002
601 RENAL TUBULAR NECROSIS 2 0.0002
602 ASTHMA 23 0.0002
603 MUSCULAR WEAKNESS 23 0.0002
604 BURNING SENSATION 14 0.0002
605 SPINAL FRACTURE 4 0.0002
606 BRAIN INJURY 2 0.0002
607 BLOOD COUNT ABNORMAL 3 0.0002
608 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
609 PLEURAL EFFUSION 12 0.0002
610 MOTOR DYSFUNCTION 2 0.0002
611 INJECTION SITE RASH 6 0.0002
612 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
613 ERECTILE DYSFUNCTION 5 0.0002
614 HELICOBACTER INFECTION 2 0.0002
615 DISEASE PROGRESSION 23 0.0002
616 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
617 SKIN ULCER 5 0.0002
618 BLOOD CHOLESTEROL INCREASED 9 0.0002
619 APLASTIC ANAEMIA 1 0.0002
620 PRODUCT ODOUR ABNORMAL 2 0.0002
621 MUSCLE SPASMS 35 0.0002
622 INJECTION SITE DISCOMFORT 2 0.0002
623 RASH ERYTHEMATOUS 9 0.0002
624 ABSCESS 3 0.0002
625 HYPOTHYROIDISM 6 0.0002
626 HOT FLUSH 14 0.0002
627 BLOOD POTASSIUM INCREASED 3 0.0002
628 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
629 SLEEP DISORDER 13 0.0002
630 GASTROINTESTINAL PAIN 2 0.0002
631 TOOTH FRACTURE 2 0.0002
632 TOOTH DISORDER 4 0.0002
633 HYPERTENSIVE CRISIS 2 0.0002
634 MALNUTRITION 2 0.0002
635 NEPHROPATHY TOXIC 2 0.0002
636 INTESTINAL PERFORATION 2 0.0002
637 FISTULA 2 0.0002
638 BLOOD PRESSURE INCREASED 27 0.0002
639 FLATULENCE 10 0.0002
640 DRUG INTOLERANCE 17 0.0002
641 BLOOD URIC ACID INCREASED 1 0.0002
642 PERICARDIAL EFFUSION 4 0.0002
643 LOCAL SWELLING 3 0.0002
644 PARAESTHESIA 27 0.0002
645 HEART RATE DECREASED 6 0.0002
646 SPLENOMEGALY 2 0.0002
647 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
648 PAIN IN EXTREMITY 50 0.0002
649 BRADYKINESIA 1 0.0002
650 COVID-19 PNEUMONIA 2 0.0002
651 DRUG ERUPTION 3 0.0002
652 DIZZINESS 84 0.0002
653 COMA 8 0.0002
654 CHOLECYSTITIS 2 0.0002
655 CARDIO-RESPIRATORY ARREST 7 0.0002
656 GOUT 3 0.0002
657 RESPIRATORY DISORDER 5 0.0002
658 MOBILITY DECREASED 12 0.0002
659 LEUKOCYTOSIS 3 0.0002
660 NOCTURIA 2 0.0002
661 CEREBRAL INFARCTION 4 0.0002
662 CYTOPENIA 2 0.0002
663 LIVER INJURY 4 0.0002
664 ABDOMINAL DISTENSION 17 0.0002
665 BLOOD GLUCOSE ABNORMAL 3 0.0002
666 TENDON RUPTURE 2 0.0002
667 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
668 ILEUS 2 0.0002
669 SWOLLEN TONGUE 5 0.0002
670 INJECTION SITE DISCOLOURATION 2 0.0002
671 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
672 HYPONATRAEMIA 9 0.0002
673 BLEPHAROSPASM 1 0.0002
674 ABDOMINAL PAIN LOWER 4 0.0002
675 NEUROPATHY PERIPHERAL 15 0.0002
676 THERAPY NON-RESPONDER 7 0.0002
677 RASH GENERALISED 4 0.0002
678 THERAPY INTERRUPTED 11 0.0002
679 DEEP VEIN THROMBOSIS 10 0.0002
680 ORAL HERPES 3 0.0002
681 SWELLING FACE 10 0.0002
682 MUSCULOSKELETAL PAIN 8 0.0002
683 ANHEDONIA 4 0.0002
684 THROMBOCYTOPENIA 17 0.0002
685 ORAL CANDIDIASIS 2 0.0002
686 PULMONARY CONGESTION 2 0.0002
687 DISORIENTATION 6 0.0002
688 HAEMATOCRIT DECREASED 3 0.0002
689 MALIGNANT MELANOMA 2 0.0001
690 ASTHENIA 56 0.0001
691 BRONCHIECTASIS 1 0.0001
692 LOSS OF CONSCIOUSNESS 19 0.0001
693 TOXICITY TO VARIOUS AGENTS 25 0.0001
694 SINUS CONGESTION 2 0.0001
695 ARRHYTHMIA 7 0.0001
696 SEIZURE 17 0.0001
697 HYPOAESTHESIA 22 0.0001
698 FEELING HOT 9 0.0001
699 ABNORMAL LOSS OF WEIGHT 1 0.0001
700 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
701 TACHYCARDIA 13 0.0001
702 ABNORMAL DREAMS 4 0.0001
703 DELIRIUM 5 0.0001
704 MASS 2 0.0001
705 RENAL IMPAIRMENT 12 0.0001
706 CARPAL TUNNEL SYNDROME 2 0.0001
707 HYPOXIA 5 0.0001
708 OSTEOARTHRITIS 6 0.0001
709 EATING DISORDER 3 0.0001
710 ABDOMINAL PAIN UPPER 29 0.0001
711 SINUS TACHYCARDIA 2 0.0001
712 RETCHING 3 0.0001
713 URINARY TRACT INFECTION 24 0.0001
714 POOR QUALITY SLEEP 3 0.0001
715 PRODUCT SUBSTITUTION ISSUE 8 0.0001
716 PRODUCT PRESCRIBING ISSUE 3 0.0001
717 DRUG EFFECT INCOMPLETE 5 0.0001
718 FLUID OVERLOAD 2 0.0001
719 NEEDLE ISSUE 4 0.0001
720 THERAPY CESSATION 7 0.0001
721 NASAL CONGESTION 8 0.0001
722 PNEUMONIA 44 0.0001
723 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
724 ARTHROPOD BITE 1 0.0001
725 IMMUNODEFICIENCY 2 0.0001
726 BACK PAIN 31 0.0001
727 BLOOD POTASSIUM DECREASED 4 0.0001
728 BREAST TENDERNESS 1 0.0001
729 APHASIA 4 0.0001
730 DEPRESSED MOOD 7 0.0001
731 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
732 AORTIC ANEURYSM 1 0.0001
733 ABDOMINAL DISCOMFORT 22 0.0001
734 MUSCULOSKELETAL CHEST PAIN 2 0.0001
735 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
736 RASH 56 0.0001
737 BASAL CELL CARCINOMA 2 0.0001
738 NAUSEA 101 0.0001
739 PRODUCT USE COMPLAINT 2 0.0001
740 DYSPHAGIA 12 0.0001
741 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
742 BLOOD ALBUMIN DECREASED 1 0.0001
743 CYSTITIS 4 0.0001
744 BLOOD PRESSURE FLUCTUATION 3 0.0001
745 MUSCLE TIGHTNESS 2 0.0001
746 OEDEMA PERIPHERAL 15 0.0001
747 PRODUCT DOSE OMISSION 8 0.0001
748 ABNORMAL FAECES 1 0.0001
749 DYSPEPSIA 12 0.0001
750 ABASIA 3 0.0001
751 VOMITING 57 0.0001
752 EXPIRED PRODUCT ADMINISTERED 4 0.0001
753 LIP SWELLING 4 0.0001
754 SKIN DISORDER 4 0.0001
755 DYSPHONIA 7 0.0001
756 PALPITATIONS 14 0.0001
757 ATRIAL SEPTAL DEFECT 1 0.0001
758 URTICARIA 20 0.0001
759 CELLULITIS 6 0.0001
760 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
761 GASTRIC CANCER 3 0.0001
762 CARDIOVASCULAR DISORDER 3 0.0001
763 HYPOPHAGIA 3 0.0001
764 GASTRIC DISORDER 4 0.0001
765 ANAPHYLACTIC SHOCK 3 0.0001
766 BLOOD MAGNESIUM DECREASED 1 0.0001
767 CARDIAC MURMUR 1 0.0001
768 ORTHOSTATIC HYPOTENSION 2 0.0001
769 RASH MACULAR 4 0.0001
770 NEUROTOXICITY 2 0.0001
771 BLOOD CALCIUM INCREASED 1 0.0001
772 DIARRHOEA 73 0.0001
773 OFF LABEL USE 99 0.0001
774 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
775 INJECTION SITE BRUISING 9 0.0001
776 INJECTION SITE HAEMORRHAGE 9 0.0001
777 GALLBLADDER DISORDER 2 0.0001
778 THIRST 2 0.0001
779 MALAISE 49 0.0001
780 GASTROENTERITIS VIRAL 2 0.0001
781 COUGH 31 0.0001
782 RESPIRATORY DISTRESS 3 0.0001
783 DYSURIA 4 0.0001
784 PROCEDURAL PAIN 3 0.0001
785 AMNESIA 7 0.0001
786 ABDOMINAL PAIN 25 0.0001
787 PANCYTOPENIA 6 0.0001
788 BACTERIAL INFECTION 2 0.0001
789 CEREBROVASCULAR ACCIDENT 18 0.0001
790 DEPRESSION 24 0.0001
791 INTENTIONAL DOSE OMISSION 3 0.0001
792 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
793 DISEASE RECURRENCE 5 0.0001
794 INJECTION SITE PRURITUS 7 0.0001
795 HERPES ZOSTER 6 0.0001
796 INJECTION SITE SWELLING 8 0.0001
797 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
798 BLOOD GLUCOSE DECREASED 5 0.0001
799 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
800 PYREXIA 36 0.0001
801 WEIGHT DECREASED 29 0.0001
802 GLAUCOMA 2 0.0001
803 PRESCRIBED OVERDOSE 2 0.0001
804 COVID-19 18 0.0001
805 HAEMORRHOIDS 2 0.0001
806 CHOKING 2 0.0001
807 HEADACHE 64 0.0001
808 ASCITES 3 0.0001
809 BODY TEMPERATURE DECREASED 1 0.0001
810 URINARY INCONTINENCE 3 0.0001
811 UPPER LIMB FRACTURE 2 0.0001
812 DRY EYE 5 0.0001
813 PSORIASIS 13 0.0001
814 LACRIMATION INCREASED 3 0.0001
815 FALL 33 0.0001
816 FATIGUE 77 0.0001
817 FLUSHING 10 0.0001
818 DEHYDRATION 13 0.0001
819 HYPERSENSITIVITY 18 0.0001
820 ARTHRALGIA 40 0.0001
821 PULMONARY HYPERTENSION 2 0.0001
822 POLLAKIURIA 4 0.0001
823 BLOOD GLUCOSE INCREASED 18 0.0001
824 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
825 HEAD INJURY 3 0.0001
826 BREAST PAIN 1 0.0001
827 DRUG INEFFECTIVE 123 0.0001
828 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
829 BLOOD CREATININE INCREASED 6 0.0001
830 CONSTIPATION 20 0.0001
831 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
832 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
833 ASPIRATION 1 0.0001
834 BLOOD GLUCOSE FLUCTUATION 1 0.0001
835 BLOOD PRESSURE DECREASED 6 0.0001
836 MEDICATION ERROR 5 0.0001
837 INFLUENZA 10 0.0001
838 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
839 THROAT IRRITATION 4 0.0001
840 BLISTER 5 0.0001
841 PANCREATITIS ACUTE 2 0.0001
842 OXYGEN SATURATION DECREASED 5 0.0001
843 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
844 SINUSITIS 9 0.0001
845 SUICIDAL IDEATION 8 0.0001
846 ILLNESS 9 0.0001
847 NEPHROLITHIASIS 4 0.0001
848 TINNITUS 4 0.0001
849 SHOCK 2 0.0001
850 NASOPHARYNGITIS 16 0.0001
851 NIGHTMARE 3 0.0001
852 CONFUSIONAL STATE 14 0.0001
853 OROPHARYNGEAL PAIN 8 0.0001
854 PAIN 53 0.0001
855 PRODUCT DOSE OMISSION ISSUE 25 0.0001
856 TREATMENT FAILURE 7 0.0001
857 WHEEZING 5 0.0001
858 ATAXIA 1 0.0001
859 FEELING ABNORMAL 20 0.0001
860 BURSITIS 1 0.0001
861 HYPERGLYCAEMIA 3 0.0001
862 CONDITION AGGRAVATED 25 0.0001
863 AGITATION 6 0.0001
864 ENCEPHALOPATHY 2 0.0001
865 CARDIOMEGALY 1 0.0001
866 BALANCE DISORDER 7 0.0001
867 ABNORMAL WEIGHT GAIN 1 0.0001
868 HEART RATE INCREASED 8 0.0001
869 EYE SWELLING 3 0.0001
870 MEMORY IMPAIRMENT 11 0.0001
871 HEPATITIS 2 0.0001
872 ADVERSE DRUG REACTION 7 0.0001
873 PERIPHERAL SWELLING 12 0.0001
874 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
875 RHINORRHOEA 5 0.0001
876 RESPIRATORY TRACT INFECTION 2 0.0001
877 ARTHRITIS 6 0.0001
878 ANKYLOSING SPONDYLITIS 1 0.0001
879 PULMONARY EMBOLISM 7 0.0001
880 ERYTHEMA 15 0.0001
881 INFLUENZA LIKE ILLNESS 6 0.0001
882 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
883 APHONIA 1 0.0001
884 BLINDNESS UNILATERAL 1 0.0001
885 CONVULSION 4 0.0001
886 PRODUCT USE ISSUE 13 0.0001
887 VAGINAL HAEMORRHAGE 3 0.0001
888 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
889 DECREASED APPETITE 16 0.0001
890 DYSSTASIA 2 0.0001
891 PRURITUS 26 0.0001
892 BRONCHITIS 5 0.0001
893 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
894 HALLUCINATION 5 0.0001
895 STOMATITIS 4 0.0001
896 PLATELET COUNT DECREASED 7 0.0001
897 LIMB DISCOMFORT 2 0.0001
898 NERVOUS SYSTEM DISORDER 2 0.0001
899 BRAIN FOG 1 0.0001
900 PRODUCTIVE COUGH 3 0.0001
901 BACK DISORDER 1 0.0001
902 LUNG DISORDER 3 0.0001
903 EYE DISORDER 2 0.0001
904 VISUAL ACUITY REDUCED 2 0.0001
905 VIRAL INFECTION 2 0.0001
906 FUNGAL INFECTION 2 0.0001
907 AGGRESSION 3 0.0001
908 HOSPITALISATION 9 0.0001
909 VISION BLURRED 8 0.0001
910 EMOTIONAL DISTRESS 7 0.0001
911 NERVOUSNESS 3 0.0001
912 MUSCULOSKELETAL STIFFNESS 5 0.0001
913 AMENORRHOEA 1 0.0001
914 DRUG WITHDRAWAL SYNDROME 5 0.0001
915 INJECTION SITE ERYTHEMA 7 0.0001
916 RASH PRURITIC 3 0.0001
917 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
918 BONE DISORDER 1 0.0001
919 RESTLESSNESS 2 0.0001
920 TREMOR 9 0.0001
921 INJECTION SITE MASS 2 0.0001
922 AGRANULOCYTOSIS 1 0.0001
923 NECK PAIN 3 0.0001
924 WEIGHT INCREASED 12 0.0001
925 COLITIS 2 0.0001
926 ANXIETY 15 0.0001
927 PRODUCT QUALITY ISSUE 7 0.0001
928 BONE PAIN 3 0.0001
929 DEATH 44 0.0001
930 CATARACT 3 0.0001
931 IRRITABILITY 3 0.0000
932 DRY MOUTH 4 0.0000
933 DEVICE BREAKAGE 2 0.0000
934 BONE MARROW FAILURE 1 0.0000
935 BODY TEMPERATURE INCREASED 1 0.0000
936 OSTEOPOROSIS 2 0.0000
937 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
938 VISUAL IMPAIRMENT 6 0.0000
939 ROAD TRAFFIC ACCIDENT 2 0.0000
940 WITHDRAWAL SYNDROME 2 0.0000
941 APPLICATION SITE PAIN 1 0.0000
942 DEVICE DIFFICULT TO USE 3 0.0000
943 INSOMNIA 12 0.0000
944 GASTROINTESTINAL DISORDER 4 0.0000
945 SKIN IRRITATION 2 0.0000
946 SKIN DISCOLOURATION 2 0.0000
947 ADVERSE EVENT 4 0.0000
948 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
949 RENAL DISORDER 2 0.0000
950 OCULAR HYPERAEMIA 2 0.0000
951 INTERSTITIAL LUNG DISEASE 2 0.0000
952 DYSGEUSIA 3 0.0000
953 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
954 LEUKOPENIA 2 0.0000
955 INCORRECT DOSE ADMINISTERED 9 0.0000
956 SPEECH DISORDER 2 0.0000
957 APPLICATION SITE ERYTHEMA 1 0.0000
958 DERMATITIS ATOPIC 2 0.0000
959 PROSTATE CANCER 3 0.0000
960 SKIN EXFOLIATION 3 0.0000
961 EYE PAIN 2 0.0000
962 RHEUMATOID ARTHRITIS 4 0.0000
963 INTENTIONAL PRODUCT MISUSE 3 0.0000
964 SURGERY 2 0.0000
965 BLADDER CANCER 2 0.0000
966 JOINT SWELLING 4 0.0000
967 THERAPEUTIC RESPONSE DECREASED 2 0.0000
968 ILL-DEFINED DISORDER 2 0.0000
969 EXPOSURE DURING PREGNANCY 2 0.0000
970 INFUSION RELATED REACTION 2 0.0000
971 SOMNOLENCE 6 0.0000
972 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
973 INJURY 2 0.0000
974 INFECTION 4 0.0000
975 UNDERDOSE 2 0.0000
976 ACCIDENTAL OVERDOSE 1 0.0000
977 ACNE 2 0.0000
978 INJECTION SITE PAIN 8 0.0000
979 DRUG DOSE OMISSION BY DEVICE 2 0.0000
980 ABORTION SPONTANEOUS 1 0.0000
981 DRUG DOSE OMISSION 4 0.0000
982 PRODUCT STORAGE ERROR 2 0.0000
983 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
984 DEVICE ISSUE 2 0.0000
985 NEUTROPENIA 3 0.0000
986 BREAST CANCER 2 0.0000
987 OVERDOSE 4 0.0000
988 ARTHROPATHY 1 0.0000
989 NO ADVERSE EVENT 3 0.0000
990 DRY SKIN 2 0.0000
991 ALOPECIA 1 0.0000